Showing results (161-170 of 210) with videos related to

Sort By:
Pageof 21
Journal of Virology|August 1, 1997
Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entryJ C Whitbeck, C Peng, H Lou, et al.
Clinical & Developmental Immunology|November 14, 2013
The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control studyS A Zavaleta-Muñiz, B T Martín-Márquez, L Gonzalez-Lopez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 20, 2021
Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 studyJ Martínez-Trufero, A Lozano Borbalas, I Pajares Bernad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood TransplantationStephen Harnicar, Doris M Ponce, Patrick Hilden, et al.
Transplantation and Cellular Therapy|November 30, 2025
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative AnalysisMohammad Alhomoud, Glenn Heller, Christina Cho, et al.
Blood Advances|July 23, 2021
Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformationOscar B Lahoud, Sean M Devlin, Molly A Maloy, et al.
Advances in Cell and Gene Therapy|November 7, 2022
Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34+-selected allogeneic transplantationChristina Cho, Patrick Hilden, Scott T Avecilla, et al.
Bone Marrow Transplantation|April 28, 2022
Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplantMaria Sola, Valkal Bhatt, Meighan Palazzo, et al.
American Journal of Hematology|September 9, 2023
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemiaKarthik Nath, Jasme Lee, Theresa A Elko, et al.
Bone Marrow Transplantation|October 10, 2017
Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysisC Cho, M Hsu, P Barba, et al.
Pageof 21